BLFS logo

BIOLIFE SOLUTIONS INC

BLFSNASDAQ
πŸ† #1700 by market capEarnings Nov 5US Equity
$34.81β–² $0.19 (+0.55%)
Market closed Β· at close
1hβ€”
24hβ–² 0.6%
7dβ–² 2.9%
14dβ–² 10.6%
30dβ–² 23.9%
1yβ–² 44.9%
🏦Market Cap
$1.70B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+34.4%
High Growth
πŸ“ŠGross Margin
63.9%
High
πŸ’΅FCF Margin
7.9%
Moderate
βš–οΈP/S Ratio
16.5x
Expensive
Otter Score
59
Weak

Trading Snapshot

Day Range
$34.38 – $35.44
52-Week Range
$17.86 – $34.93
Volume
$2.53B
Avg Volume
$2.03B
Shares Outstanding
48.9M
Next Earnings
Sep 22, 2026

Fundamentals Snapshot

Annual Revenue
$96M
Last Q Revenue
$28M
P/E Ratio
29.2
P/S Ratio
16.5x
EPS (TTM)
$1.18
Dividend Yield
β€”

Why Investors Own BLFS

  • βœ“High-growth profile β€” revenue up +32.9% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 44% gross margin and 20% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$96Mβ–² +33.8% YoY
Gross Margin (TTM)
43.6%β–² +1.9% YoY
Operating Income (TTM)
$10Mβ–² +33.8% YoY
Free Cash Flow (TTM)
$19Mβ–² +33.8% YoY

About BIOLIFE SOLUTIONS INC

BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing. Key products include proprietary biopreservation media, such as HypoThermosol FRS and CryoStor, which are engineered to minimize delayed cell damage and death typically associated with preservation. Complementing these are the ThawSTAR products, an automated line of devices for thawing vials and cryobags, designed to precisely manage the heat and timing for optimal biologic material thawing. BLFS also provides innovative cloud-connected evo shipping containers for the passive storage and secure transport of temperature-sensitive biologics and pharmaceuticals. Additionally, its comprehensive range encompasses liquid nitrogen laboratory freezers, various cryogenic equipment and accessories, and specialized storage services for biological and pharmaceutical products. Products are distributed both directly to customers and through a network of third-party distributors. Established in 1987, BioLife Solutions, Inc. maintains its headquarters in Bothell, Washington.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
59/100

Analyst Price Target

β“˜
Average Target
$34.97
β–² +0.5% Upside
High Target$43.68
Low Target$31.10
Based on 16 analysts

Latest News & Updates